SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " dru " 1,973 found 🔀 AI-powered Shuffle
He bought a fitness supplement online to bulk up, but ended up losing his mind
Daniel Murphy's mental health spiralled after he took missold drugs which had been mixed with steroids.
FDA clears autoinjector drug for home treatment of heart failure edema
A new drug delivery system may help reduce heart failure hospitalizations and related healthcare costs, which are expected to reach $70 billion by 2030.
Amgen discloses data breach, says patient information was stolen
Drugmaker Amgen said on Friday hackers stole company data and patient health information in a cybersecurity breach involving cloud storage systems run by third-party providers.
How scientists are trying to repair the body from within: Regenerative medicine and anti-aging
At Scripps Research and its drug discovery arm, the Calibr-Skaggs Institute for Innovative Medicines, scientists are developing regenerative medicine therapies designed to help the body repair itself from within. Unlike traditional medicines that primarily manage symptoms or slow disease progression, regenerative medicine aims to restore damaged tissues and rebuild function lost to aging and disease. Researchers are advancing programs focused on the heart, lungs, digestive tract and eyes, including investigational therapies for heart failure, idiopathic pulmonary fibrosis, inflammatory bowel disease, age-related macular degeneration and other chronic conditions that become more common as we age. Learn how scientists are activating the body’s natural repair mechanisms to explore a future where medicine may not only treat disease, but help reverse its damage.
Innovation Politics at the FDA - Petrie-Flom Center
The relationship between innovation and the Food and Drug Administration (FDA) has become a central topic of concern for a whole host of parties: academics, members of the National Academies of Sciences, Engineering, and Medicine, and several former FDA commissioners.
Maine GOP candidate outlines plan to fight drug addiction
Following a tour of Phoenix House in Lewiston, Charles said he would put in place more services to help those struggling with addiction, particularly in the immediate aftermath of the administration of Narcan, which reverses overdoses.
Tony Romo placed on leave by CBS after drunk driving charge
In Romo's place, JJ Watt will join Nantz and Tracy Wolfson as CBS Sports' lead NFL team during, CBS said Friday.
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next
Peptides have become one of the hottest trends in wellness, with promises like faster muscle recovery and healthier aging. And six of these compounds cleared a major hurdle last week, when an advisory panel to the US Food and Drug Administration voted in favor of making them available through compounding pharmacies.
CMS announces end to Medicare Part D prescription drug subsidies
With the change, premiums are expected to rise. However, the Centers for Medicare & Medicaid Services confirmed they cannot inflate by more than 6%, as capped by the Inflation Reduction Act.
Rockies' Goodman Listed as Top Catcher at MLB Trade Deadline
The trade drums are beating louder as Colorado Rockies catcher Hunter Goodman is slotted as the No. 1 catching option as the MLB Trade Deadline draws closer.
Harvard Business School announces 2026-2027 Blavatnik Fellows
Harvard Business School (HBS) has named its 2026-27 Blavatnik Fellows. The fellowship offers HBS alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new life science technology ventures and develop their leadership talents during a 12-month fellowship year. To date, Blavatnik Fellows have founded 50 biomedical companies developing innovations including gene writing technologies, engineered cell therapies, oral biologic drug delivery platforms, AI-enabled digital health solutions, and therapeutics for cancer, neurological, and metabolic diseases. Collectively, Fellows have raised more than $800 million in private and public capital to advance their ventures.
The new "science golden age" looks suspiciously like a grift
This edition of PN is made possible by paid subscribers. Become one ⬇️ 🚀 Subscribe to PN 🚀 The Trump regime is trying to usher in a “Golden Age in Science” where scientific research is run like a Trump family business, artificial intelligence is all that matters, profit is everything, and expertise is for chumps. Or at least that’s the vision emerging from a new 123-page “Report to the President” from Michael Kratsios, the Director of the White House Office of Science and Technology Policy. In a normal administration, you could probably skip over learning about a science policy document — but this is no normal administration, and this is no normal science policy document. Instead, it’s Trump’s attempt to end the actual golden age of science that was kicked off in 1945 with the publication of '“The Endless Frontier” by Vannevar Bush. [ ](https://www.publicnotice.co/p/harmeet-dhillon-portland) [ Harmeet Dhillon demonstrates danger of posting through it ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Liz Dye · Jul 29 [ Read full story ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Bush, at President Franklin Delano Roosevelt’s request, laid out a vision of federal support for science that centered on funding universities to do basic research, saying that as long as those institutions were “vigorous and healthy and their scientists are free to pursue the truth wherever it may lead, there will be a flow of new scientific knowledge to those who can apply it to practical problems in Government, in industry, or elsewhere.” Kratsios’s report is supposed to be the successor to Bush’s, and even apes the format, but this isn’t really a document about science policy. It’s one about ending science research as we know it in favor of shoveling cash at big tech companies. While it might be temping to wave this away as an aspirational policy document, Trump has already begun to shift billions in research funds to AI projects and has taken a hatchet to science funding across the board. He’s teed up the shift Kratsios proposes here, and since neither Congress nor the Supreme Court seem inclined to stop him from doing whatever he wants with taxpayer money, it isn’t doomering or hyperbole to say we are staring down the barrel of a world where the only “science” the government intends to support is for-profit tech and defense advancements. Science for dummies Part of how you can tell this isn’t a document about science is that you are immediately faced with an absolute wall of business-speak of the worst sort. Did you know we must “tightly couple our science and technology enterprises to ensure that groundbreaking ideas invented in the United States are rapidly prototyped, tested, manufactured, and scaled domestically”? You do now! That tone isn’t surprising, because Kratsios has no background in science or research. He has a bachelor’s in political science and spent most of his career working for Peter Thiel at Thiel Capital. After a stint in the first Trump administration as Chief Technology Officer, where he also did not do any science, Kratsios was tasked in 2020 with overseeing the Pentagon’s research budget for a brief time, a position that, as the Wall Street Journal put it, “carries a great deal of power in terms of dictating investment allocations.” He spent the Biden years at Scale AI as “head of strategy,” which you will also note is neither a science nor a research job. But Scale AI has contracts with the Department of Defense and, as the Washington Post wrote in 2023, “has been aggressively pitching itself as the company that will help the US military in its existential battle with China.” And now you have the necessary background for our new golden age, which is going to be a golden age of taking money away from scientists and universities and giving it to companies like Scale AI. A note from Aaron: Working with brilliant contributors like Lisa takes resources. If you aren’t already a paid subscriber, please become one to support our work. 👇 Subscribe In a genuinely galling move, Katsios spends a lot of time slamming universities because of “administrative burdens on researchers” and the “well-documented inefficiencies” in academia, the message being that those damn universities waste the time of amazing researchers with paperwork. Except it’s the administration that is attempting to impose inefficient, unnecessary burdens on those researchers with a proposed Office of Management and Budget rule that would require senior political appointees to approve every science grant and ensure it aligns with Trump’s personal priorities. Researchers would also have to seek prior government approval to attend conferences or publicize their research. And political appointees could terminate any grant at any time if they feel like it. [ ](https://www.publicnotice.co/p/omb-rule-science-funding) [ The murder of expertise ](https://www.publicnotice.co/p/omb-rule-science-funding) Lisa Needham · Jun 11 [ Read full story ](https://www.publicnotice.co/p/omb-rule-science-funding) But when it comes to AI, we’re going to “restore permissionless innovation.” The report proposes to give lucky ducky innovators a pile of cash up front for grants lasting five years or longer, saying “awards should be fully-funded in year one, with all resources earmarked upfront, to minimize administrative burdens and reduce pressure for researchers to generate intermediate results to secure continued funding.” Yeah, wouldn’t want to have to make the Very Special Tech Bros show results or get money parceled out year by year like the plebes at universities. The report also proposes that we should have “fast grants” with “simplified applications requiring just a few pages of writing” because that is definitely how science works, just writing a bit off the dome and getting some cash. [ ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) [ Tech elites are turning AI into ChatGPTrump ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Paul Waldman · July 29, 2025 [ Read full story ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Oh, and we should have prizes and challenges, where multiple teams compete. The proposed prizes include incentives like “advance procurement commitments,” which means the federal government agrees to buy whatever is being developed. There’s also “regulatory fast-tracking,” making sure all those great AI thingies don’t have to wait too long to be unleashed on a market. These aren’t incentives to do science. These are incentives to develop things with tax dollars that you can then sell to the government for more tax dollars. In the suggestion that might be the most unhinged, the most very opposite of how both government and research work, our new age will include “golden tickets.” That’s where an individual reviewer in an agency — yes, just one person — can “recommend unconventional proposals that may not pass consensus-driven review panels” because somehow this will “surface valuable ideas too divisive for committees and attract higher quality reviewers by empowering them to exercise independent scientific judgment.” Yes, that’s saying that a random person in an agency should be able to shovel money at some idea even if it can’t pass a review panel, and that the opportunity to do so will attract better employees because apparently all the best minds in science are chomping at the bit to be allowed to unilaterally fund AI research based on their personal vibes. But that isn’t at all how actual science works, and actual scientists aren’t unhappy about review panels. They work collaboratively, not siloed in some secret race to create the next AI chatbot. A 2020 study by the National Bureau of Economic Research examined whether peer review panels succeed in helping agencies predict which research ideas will best advance science. Peer review was better at finding “diamond in the rough” applicants than a single government program official. How about that. Trump always wants a taste It’s painfully clear that what Katsios is trying to do here is turn the whole of government science research and funding into the sort of “move fast and break things” paradigm that is the hallmark of big tech. That method works to line the pockets of tech executives, but it isn’t science. There’s a reason the government funds different kinds of research than private tech companies do. What Katsios either fails to understand or deliberately ignores is that the federal government is the main funder of basic research precisely because it can take a long time for it to bear fruit and is not intended to be profitable as such. “Basic” here does not mean rudimentary or simple, but rather research that is designed to advance scientific knowledge instead of achieving a specific outcome or product. Big tech companies don’t widely fund that sort of research, because it doesn’t make them money. Industry dollars account for only about 20 percent of basic research funding, while the government contributes around 60 percent. Big tech companies and startups do, however, rely on and benefit from that basic research. A 2019 study found that 35 percent of all patents obtained by venture-backed startups from 1976 to 2016 cited federally supported research. Basic research funded by the NIH contributed to every single drug the FDA approved from 2010 to 2016. [ ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) [ The Saudi nuclear farce and governance by whim and meme ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Noah Berlatsky · Jul 27 [ Read full story ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Unlike inventing the next ChatGPT, actual science is slow and iterative. Government funding of research that, on its face, would not appear to lead to any big new invention is actually what underpins those big new inventions. If the government hadn’t funded research into desert lizard venom, we wouldn’t know about semaglutide, and we wouldn’t have Ozempic. If research scientists hadn’t studied how bees optimize nectar foraging within a colony, we wouldn’t have the algorithm that assigns internet traffic across computer servers. The report assiduously ignores that a symbiotic, profitable relationship between the federal government, universities, and private companies already exists. Each federal research dollar generates about $1.50 to $3.00 in long-term economic benefits. The $36 billion the government awarded in NIH research funding in fiscal year 2025 generated $94 billion in new economic activity. Trump’s proposed new golden age is intended to strip those billions from universities, resulting in the dismantling of departments and the shuttering of labs. But Katsios has a plan for that: Universities should just become trade schools to churn out no-show STEM degrees! “Require universities and community colleges to embed practical technical training and externships into STEM curricula. Let hands-on experience and industry credentials count toward degrees.” It’s quite the feat to, on the one hand, strip schools of funding for scientific research while simultaneously demanding to control what is taught and, oh, also, colleges need to give degrees to employees at big tech companies just for being employees at big tech companies. The new golden age would also exacerbate the brain drain Trump’s policies have already caused. Nature found that in the first quarter of 2025, US scientists submitted 32 percent more job applications abroad than in 2024. A March 2025 poll by Nature of roughly 1,600 scientists found that over 1,200 said they were considering leaving the country. Europe is investing $565 million to make it a “magnet for researchers” and provide funding for scientists who relocate. The new golden age is also about embedding Trump’s xenophobia into the fabric of American science. The report complains of an “over-reliance on foreign students” that “creates a security challenge our institutions are ill-equipped to address” and that a “reliance on foreign talent sidelines American students.” This is, to put it mildly, nonsense. International students pay far higher tuition and often receive no financial aid. Their tuition dollars are what make it possible for American students to get financial aid. In the 2023-2024 school year alone, international students contributed $43.8 billion to the US economy and supported over 378,000 jobs. Those 1.1 million international students accounted for only six percent of the total number of students in higher education that year, but were such an economic engine that for every three international students, one job was created or supported. It’s impossible not to wonder whether part of Trump’s loathing for universities and their leading role in scientific research is that there is no way for him to corrupt the process and make money off it in the same way he can by giving millions and billions to Silicon Valley types who, in turn, give him millions in cash. There’s no way for his children to invest in universities that the government then gives no-bid contracts to, fattening the family’s bottom line, which is pretty much the Trump sons’ current venture capital practice. Trump and Katsios’s view of science is narrow, cramped, and wrong. We’re not in a crisis, we’re not a failed state. We’ve been a science superpower for decades, and the only thing that threatens that is Donald Trump. Tech bros are already living high off the hog in this administration. They don’t need any more of our tax dollars. Hopefully this new golden age never comes to pass. Thanks for reading Public Notice. This post is public so feel free to share it. Share We’ll be back with more tomorrow. If you appreciate today’s PN, please do your part to keep us free by signing up for a paid subscription. 🚀 Subscribe to PN 🚀 Thanks for reading, and for your support.
Proposals to lower health costs get broad support in battlegrounds
Voters in battleground states and congressional districts tend to voice support for proposals in Congress that would expand access to health care or lower drug costs — often irrespective of their party affiliation — according to new polling from the University of Maryland. The poll, first shared with CQ Roll Call, surveyed people in 11 competitive states like Pennsylvania, Georgia […]
Cigna raises annual profit forecast on strength in health services unit
Cigna on Thursday raised its annual profit forecast, after beating quarterly earnings estimates on growth in its pharmacy and specialty drug businesses.
Florida urges doctors not to prescribe mental health medication for children
Florida's surgeon general has warned doctors not to prescribe antidepressants and other psych drugs for children, instead urging comprehensive evaluations and behavioral therapy as first line treatment options.
Chemical mix-up leads to hazmat response at Huntington Beach business
A hazardous materials team responded to what appeared to be a chemical mix-up that caused a reaction Wednesday morning at a business in Huntington Beach. The business in the 15200 block of News Boy Circle was evacuated after firefighters and hazardous materials experts responded to the property. Authorities said a chemical was mixed into another chemical in a 55-gallon drum,…
Rider professor appointed to NJ One Health Task Force
Daniel Druckenbrod will work to improve human, animal and environmental health within New Jersey
Trump administration to end Medicare Part D subsidy program in 2027
The prescription drug benefit is used by millions of seniors.
Biogen Beats Estimates as New Medicines Overtake MS Business
Biogen Inc. reported quarterly revenue and adjusted earnings that beat analysts’ expectations as sales of newly acquired kidney and eye-disease drugs helped offset declining revenue from multiple sclerosis medicines.
The Trump administration is halting a Medicare drug subsidy. Will premiums rise?
A temporary subsidy that reduced monthly premiums will end, and insurance companies are examining the impact.
CASPR Ends Tenagrity Contract as Agenda Turns to Gambling
Center for Addiction Science terminates Tenagrity Solutions lobbying contract focused on GLP-1 drug access. Read the latest policy update.
More than 700 cyclosporiasis cases reported in North Carolina: health officials
WLOS News 13 provides local news, weather forecasts, traffic updates, notices of events and items of interest in the community, sports and entertainment programming for Asheville, NC and nearby towns and communities in Western North Carolina and the Upstate of South Carolina, including the counties of Buncombe, Henderson, Rutherford, Haywood, Polk, Transylvania, McDowell, Mitchell, Madison, Yancey, Jackson, Swain, Macon, Graham, Spartanburg, Greenville, Anderson, Union, Pickens, Oconee, Laurens, Greenwood, Abbeville and also Biltmore Forest, Woodfin, Leicester, Black Mountain, Montreat, Arden, Weaverville, Hendersonville, Etowah, Flat Rock, Mills River, Waynesville, Maggie Valley, Canton, Clyde, Franklin, Cullowhee, Sylva, Cherokee, Marion, Old Fort, Forest City, Lake Lure, Bat Cave, Spindale, Spruce Pine, Bakersville, Burnsville, Tryon, Columbus, Marshall, Mars Hill, Brevard, Bryson City, Cashiers, Greer, Landrum, Clemson, Gaffney, and Easley.
Florida's new child mental health guidance aligns with RFK Jr.'s push to curb psychiatric drug use
The state's new guidelines echo the Make America Healthy Again movement's call to reduce psychiatric medication use in children.
An entirely new kind of drug will help us treat the untreatable
The first of a new generation of drugs that works in a completely different way to existing ones has been approved. Columnist Michael Le Page says this approach could transform treatments for all kinds of conditions
National Survey on Drug Use and Health shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people
Federal survey shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people.
Federal survey shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people
Federal survey shows promising trends for youth mental health and drug use
A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, especially among young people
Antibiotic recalled after cardboard particles found in solution
Patients given the drug in question could face an increased risk of blood vessel blockages or inflammation.
Biodegradable implant can deliver targeted cancer immunotherapy while protecting healthy tissue
Scientists at Houston Methodist Research Institute have developed a biodegradable implant designed to deliver cancer-fighting immunotherapy drugs directly into tumors over an extended period, a strategy ...
National Survey on Drug Use, Mental Health
RDML. Christopher Jones, SAMHSA Acting Director, joins the show to talk about the recent SAMHSA survey.
Peptides are the latest wellness trend – but do they work?
A drug advisory committee in the US has recommended approval for several experimental peptides. But there have been no large-scale tests of these new compounds in humans, finds columnist Grace Wade
Pharma’s drug spending deflection
Job lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.
2026 Baseball Hall of Fame induction: Carlos Beltrán, Andruw Jones, Jeff Kent speak of national, organizational pride while enshrined
Carlos Beltrán, Andruw Jones and Jeff Kent inducted into Baseball Hall of Fame
The National Baseball Hall of Fame officially welcomed three new members into its prestigious institution.
Drug-Resistant Superbugs May Be Jumping Between Pets And Humans, Scientists Warn
Livestock aren't the only issue.
High drug prices anger the public. Steep hospital costs elicit yawns. Why is that?
How is it that pharma companies—and, by extension, health insurers that cover drugs—have targets on their backs while hospitals live like wallflowers?
Synth historian Oli Freke will spend big on a good bicycle
He’s hard at work on the upcoming Beat Gems, a gorgeous coffee-table book about the history of drum machines.
Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.
People with obesity in the United States are being sorted between haves and have-nots.
‘Ozempic face’ and hair loss: what evidence is there for weight-loss drug side-effects?
Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known
Oral GLP-1 drugs may quiet the brain’s food craving circuit
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Matt Mindrum: Don’t put a moratorium on Indianapolis’ growth
Marion County's data center moratorium sends a message that Indianapolis is becoming less open to business. It risks turning away billions in investment from some of the world’s fastest-growing industries.
ACC shares updated recommendations for managing HFpEF
A team of specialists detailed new data and recent breakthroughs in the diagnosis, management and treatment of heart failure with preserved ejection fraction.
FDA panel votes to loosen restrictions for controversial peptides
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
U.S. health officials investigate new outbreak of parasite cyclospora
The Food and Drug Administration has not yet identified which products are linked to the illnesses.
Barren woman arrested, accused of selling marijuana at her business
A Barren County woman was arrested Wednesday on suspicion of illegally selling marijuana from her business. Agents with the Barren River Drug Task Force and inspectors with the Kentucky Department […]
Harvard Pilgrim, Tufts Health Plan CEO talks GLP-1 weigh-loss drug coverage
A year in, Point32Health CEO sits down to discuss insurance premiums, drug prices, and layoffs.
Federal government to spend $5B on AI-powered health, infrastructure research
More than 15 federal agencies will use AI to investigate the root causes of chronic diseases, develop treatments for pediatric cancer, expedite the discovery of prescription drugs and enhance U.S. energy infrastructure, among other related…
RELEASE: Gottheimer Hosts Telephone Town Hall to Discuss Health Care Costs, Medicare, Social Security, Utility Prices, Affordability in Jersey
Above: Gottheimer conducts a Telephone Town Hall with North Jersey families. WASHINGTON, D.C. — Last night, July 22, 2026, U.S. Congressman Josh Gottheimer (NJ-5) hosted a Telephone Town Hall with thousands of North Jersey residents to discuss his bipartisan efforts to lower health care and prescription drug costs, protect Social Security and Medicare, cut taxes, lower […]
Knicks Big Man Questions NBA 2K’s Victor Wembanyama Decision
On Wednesday, July 22, NBA 2K released the cover athletes for NBA 2K27. Representing today’s NBA will be San Antonio Spurs center Victor Wembanyama. Shortly after the Wemby reveal, New York Knicks center Andre Drummond took to X to question the decision behind having Wembanyama–and not Jalen Brunson–as the cover selection. Knicks Big Man Questions […] The post Knicks Big Man Questions NBA 2K’s Victor Wembanyama Decision appeared first on HEAVY.
Common Weight Loss Drugs Have Been Linked to a Higher Risk of Hair Loss
Here are the stats.
Officials: Barren County business owner arrested, charged with trafficking drugs out of storefront
Law enforcement agencies served a search warrant that led to a drug trafficking arrest.
Why aren’t health insurers rushing to cover GLP-1 prescriptions for beneficial weight loss?
In theory, GLP-1 receptor agonist drugs like semaglutide and tirzepatide should save a lot of money for the health insurers that pay for them. As it turns out, the lived reality is not keeping pace with the idealistic expectation.
Australian woman gives birth to identical quadruplet girls, a medical rarity
The chance of conceiving monozygotic quadruplets is 1 in 15 million, a maternal fetal specialist said.
FDA sees early promise in new gene therapy for BAG3-associated DCM
An investigational drug therapy from Affinia Therapeutics has secured the FDA's orphan drug designation. This means the company now has access to certain benefits, including tax credits and fee exemptions, as it works toward approval.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts call for the FDA to prioritize scientific expertise over political influence in drug reviews amid recent leadership changes and staffing challenges.
Health Committee advances Collins’ insulin price cap over GOP objections - Live Updates
The bill would limit the private insurance price for the diabetes drug to $35. Its approval by the GOP-led panel was highly unusual.
Samsung Biologics: geographic diversification is a sound business decision
Samsung Biologics has been on a steep upward growth trajectory since receiving its first licence to produce biologic drug substances in 2015.
Wyss Institute receives Massachusetts Life Science Center award to advance metabolomics and lipidomics research across Massachusetts ecosystem
By Benjamin Boettner (BOSTON) — The Wyss Institute at Harvard University has received an award from the Massachusetts Life Science Center (MLSC), enabling it to host a next-generation metabolomics and lipidomics analytical platform. The platform will allow its researchers to creatively pursue new approaches to biomarker and drug discovery across multiple health challenges the Institute...
US to spend $5 billion on health, construction research powered by AI
Agencies will use the funding to identify the root causes of chronic diseases, accelerate drug discovery, develop longer-lasting building materials.
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying...
Large Sterling Heights police operation swarms SW Detroit business
Also at the scene was the Drug Enforcement Agency, K-9 police units and officers wearing tactical fatigues and helmets.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Does the science of peptides live up to the hype?
Synthetic peptides are getting some serious hype, from fitness influencers on your FYP to people seeking new options for chronic conditions. And while the human body already makes peptides, like insulin and the hormone oxytocin, most of the viral synthetic peptides are not approved by the Food and Drug Administration. Scientists say that raises some big concerns about safety and efficacy. So ahead of this week’s FDA meeting to discuss seven commonly used peptides, we get into the science with health reporter Sarah Boden.Interested in more science behind health trends? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. It includes perks like bonus episodes, early access, archive access, curated playlists and sponsor-free listening. Learn more at plus.npr.org.
An Australian woman gives birth to rare identical quadruplet girls
An Australian woman has given birth to identical quadruplet girls after a pregnancy doctors described as incredibly rare
DEA agents conduct operation at West Knoxville business
KNOXVILLE, Tenn. (WATE) — Federal drug investigators were spotted at a business in West Knoxville on Tuesday. A spokesperson for the Louisville Field Division of the Drug Enforcement Administration…
Attempted kidnapping, break-in at day care likely tied to mental health issues, docs say
Two separate incidents, which according to court documents, are likely related to mental health issues and drug psychosis.
There’s a right way to regulate drugs. Kratom is no exception.
Kratom, social media use in teens, New York's data center moratorium and more, in readers' eyes.
Automated Neurofeedback: Rewiring the Future of Mental Health Care
Mental health and addiction disorders continue to rise across the United States, affecting veterans, adolescents, families, first responders, and entire communities. According to the National Institute on Drug Abuse, nearly half of individuals with a substance use disorder also experience a co-occurring mental health condition. At the same time, healthcare systems are struggling with workforce ...
WVU Health leadership failed to address painkiller thefts as opioids devastated West Virginia
WVU Health Systems has entered into a federal settlement for failing to report and prevent drug thefts by employees.
FDA’s Home as a Health Care Hub Initiative and the READI-Home Innovation Challenge: Key Takeaways for Device Sponsors
Key Takeaways The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) opened its READI-Home Innovation Challenge, offering up to nine device sponsors early,…
Anthropic's life sciences plans: Mystery programs, Nobel hires, M&A and big ambition
Anthropic pushes into life sciences with a $400M Coefficient Bio deal, Nobel hire John Jumper, Claude Science launch and its own drug pipeline.
The next step of site-neutral, and a fiery PBM hearing
Medicare proposes to reduce payments to hospitals for certain drugs and imaging services.
Need surgery or prescriptions? How to deal with prior authorization challenges
Prior authorization: Why insurers require approval for some drugs, tests and procedures.
New Poll: 94% of Americans Say Congress Must Act on Health Care Costs, as Families USA Convenes Bipartisan Policy Symposium
Both House and Senate committees are marking up legislation on hospital price transparency, prescription drug and Medicare Advantage reform. WASHINGTON, D.C. – A new national poll shows that 94% of Americans believe it is important for the President and Congress to take action to lower health care costs. The poll was commissioned by Families USA, […]
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
The pharmaceutical company has demonstrated how AI can transform how drugs discovery and is now scaling AI across R&D to accelerate the discovery of next-generation medicines.
Test that found source of US explosive diarrhoea outbreak was false positive, health officials say
The latest update from the US Food and Drug Administration means the exact source of the parasite is still not known.
U.S. health agency now says cyclospora finding at produce company was false positive
The U.S. Food and Drug Administration said on Sunday that laboratory experts re-reviewed sample results in the Taylor Farms Cyclospora investigation and concluded the finding should be considered a false positive.
Scientists discover a protein that protects the brain from Alzheimer’s damage
A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atrophy, and healthier connections between neurons, while mice without it experienced more severe damage. The findings also revealed a possible drug target that could help control harmful activity in supporting brain cells.
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
Opinion | Double standard over GLP-1 drugs hits women especially hard
Women experience the effects of obesity in many ways, including heart disease, certain cancers, fertility challenges, maternal health complications, and more severe menopause symptoms.
Photos: Afrifest: Taste of Africa at Sawyer Point 2026
The festival features Africa and the Caribbean traditional drumming and cultural dance performances, music, attire and food at Sawyer Point Park.
Brandon Woodruff announces he needs season-ending shoulder surgery
Brandon Woodruff announced July 18 he needs season-ending shoulder surgery but that he's not retiring and intends to try to come back again.
Brass at the Beach brings musical excitement back to Myrtle Beach
The Drum Corps International Brass at the Beach returns to Doug Shaw Stadium on Tuesday, July 28 at 7 p.m.
Weight-loss drugs may improve job prospects and dating odds for one group
A weight-loss specialist says GLP-1 results boost confidence in job interviews and dating, but the study found no clear improvement in well-being.
GSK’s drops chronic cough drug, dampening $2bn Bellus Health bid
GSK will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.
U.S. health officials zero in on source of Cyclospora outbreak
The U.S. Food and Drug Administration (FDA) is zeroing in on the source of a parasitic outbreak linked to iceberg lettuce that has sickened hundreds of people across five states.
I've been on PrEP for 11 years. Access to the HIV prevention drug is in danger.
Several interconnecting barriers continue to hinder PrEP access and exacerbate HIV prevention disparities.
Hochul drums up support for data center moratorium
The roundtable included perspective local government leaders, those in the agricultural industry, and utility advocates who stressed the need to plan ahead
The great 340B debate: Point vs. counterpoint vs. finger points
From the right come heated calls for reform if not outright overhaul of the 340B Drug Pricing Program. From the left, vociferous insistence on letting 340B be, albeit with modest tweaks and fixes. From hospitals and drug manufacturers: finger-pointing.
New Alzheimer's drug repairs DNA damage and reduces brain inflammation
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
SF overdose deaths decline as public health officials expand treatment, drug monitoring
Overdose deaths in San Francisco have declined compared to last year, a trend local public health officials say reflects both national patterns and the city's ongoing efforts to expand treatment and other interventions.
Trump officials want to make testosterone drugs easier to prescribe. Is that a good idea?
Officials under President Donald Trump want to make it easier for men to get a prescription for testosterone, the latest shift in a decades-long debate over the benefits and risks of replacing the hormone that affects sex drive, mood and other health factors.
Boone Co. man sentenced for major drug bust at Roscoe business
A Caledonia man finds out his prison sentence after pleading guilty to trafficking fentanyl and methamphetamine in 2022.
Jillian Michaels warns against social media health advice as ‘healthmaxxing’ trend goes viral
‘Keeping It Real’ podcast host Jillian Michaels discusses the viral ‘healthmaxxing’ trend and GLP-1 drugs on ‘Fox & Friends.’
Merck’s cholesterol pill gets US FDA approval
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s nod, bolstering the drugmaker’s efforts to diversify beyond its blockbuster cancer treatment Keytruda.